Clinical Trial

Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to determine the effect of a low carbohydrate higher protein diet, modelled after the Atkins program on weight loss, glycemic control, risk markers of cardiovascular disease and body composition in patients taking semaglutide. Participants will: * Be randomized to follow either a low carb, higher protein diet or a low fat diet for 3 months. * Visit the clinic at week 2, 4, 8 and 12 to meet with a dietician, fill out a symptoms questionnaire and for bloodwork * Complete 3-day food records 4 times over the 12 weeks.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-01; most recent amendment 2026-02-13.
Status change: Active, Not Recruiting → Completed 2026-02-13
Trial Details
NCT Number NCT07280403
Lead Sponsor INQUIS Clinical Research
Collaborators: Simply Good Foods USA, Ltd.
Conditions Weight Loss
Enrollment 60 participants
Start Date 2024-09-12
Primary Completion 2025-10-14 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-18